Key Takeaways
ICD-10 Code M36.8 describes systemic disorders of connective tissue in other diseases classified elsewhere, a billable ICD-10-CM manifestation code.
M36.8 is valid for FY2026 HIPAA-covered transactions and has been effective since October 1, 2015.
A Code first instruction requires coders to report the underlying disease alongside M36.8; sequencing errors are a common audit trigger.
Pabau’s claims management software helps practices document and submit M36.8 codes accurately across HIPAA-covered transactions.
ICD-10 Code M36.8 covers systemic disorders of connective tissue that arise as manifestations of other diseases classified elsewhere in ICD-10-CM. It sits within the musculoskeletal system chapter (M00-M99), under the M30-M36 block for systemic connective tissue disorders.
Per the CMS ICD-10 codes guidance, M36.8 is a billable, specific code valid for submission on HIPAA-covered transactions for FY2026. It follows the same sequencing structure as every ICD-10-CM manifestation code: the underlying disease is coded first, and M36.8 is reported alongside it.
This article covers code details, applicable conditions, excludes notes, the Code first instruction, sibling codes, clinical documentation requirements, and FY2026 validity.
Code details at a glance
The table below summarizes the essential reference data for ICD-10 Code M36.8 that coders and billers need before submitting claims.
Applicable to conditions
M36.8 does not carry its own Applicable to note in the ICD-10-CM tabular. Instead, it carries a Code first instruction: coders must sequence the underlying systemic disease before M36.8 whenever one of the following conditions is documented as the cause of the connective tissue involvement.
The ICD-10-CM tabular lists the following underlying diseases under the Code first instruction for M36.8. When connective tissue involvement occurs in the context of one of these conditions, M36.8 is the appropriate manifestation code, provided the underlying disease is also coded.
- Alkaptonuria (E70.29)
- Hypogammaglobulinemia (D80.-)
- Ochronosis (E70.29)
Sickle-cell disorders, hypersensitivity reactions, and other blood or immune-system manifestations are not part of the M36.8 Code first list; those presentations are coded using their own dedicated M36 sibling codes (M36.2, M36.3, and M36.4).
Practices treating patients with alkaptonuria, hypogammaglobulinemia, or ochronosis should ensure the clinical record captures both the primary diagnosis and the systemic connective tissue manifestation separately. The AAPC ICD-10-CM lookup provides cross-referencing to confirm the current Code first list against the annual tabular.

Excludes1 and Excludes2 notes for ICD-10 Code M36.8
Excludes notes are among the most common sources of claim denials in connective tissue disease coding. Submitting a code combination that violates an Excludes1 note is a code-selection error, and payers audit these combinations specifically.
Excludes1 (cannot be coded together with M36.8)
M36.8 does not carry an Excludes1 note in the ICD-10-CM tabular. There are no codes designated as mutually exclusive with M36.8, so coders do not need to check for Excludes1 conflicts before submitting this code.
Excludes2 (not included here, but may coexist with M36.8)
Excludes2 means these conditions are not classified under M36.8 but may legitimately coexist. When documented by the clinician, an Excludes2 code can be reported at the same encounter as M36.8 if clinically appropriate. This note is inherited from the parent M36 category.
- Arthropathies in diseases classified elsewhere (M14.-)
Coders managing rheumatology, internal medicine, or physical therapy billing should review the full excludes structure using the CDC/NCHS ICD-10-CM web tool to verify current FY exclusion lists, as these can shift between annual releases.
Code first instruction: sequencing ICD-10 Code M36.8
M36.8 carries a mandatory Code first instruction: a critical sequencing requirement, not a suggestion. Missing it is one of the top causes of claim denial and RAC audit findings for this code range.
The Code first instruction requires coders to also report the underlying disease that is causing the systemic connective tissue disorder. In practice, this means M36.8 is never the only code on the claim for these presentations.
- Sequence the underlying disease first (the etiology code)
- Report M36.8 as an additional code (the manifestation code)
- Both codes must appear on the claim for the encounter to be coded correctly
The ICD-10-CM official coding guidelines published annually by CMS and NCHS govern manifestation code sequencing across the entire classification. The etiology/manifestation convention is described in Section I.A.13 of those guidelines. Practices in rheumatology, internal medicine, or osteopathic care benefit from HIPAA-compliant coding workflows that enforce dual-code documentation at the point of care rather than in post-encounter review.
Pro Tip
Before submitting any claim with M36.8, confirm the underlying systemic disease code appears as the first listed diagnosis. Payer diagnosis-code edits and clearinghouse claim scrubbing will reject claims where the manifestation code appears without its required etiology code.
Parent code and sibling codes in the M36 category
M36 codes cover systemic disorders of connective tissue arising in diseases classified elsewhere. Selecting the most specific code within this category is a core ICD-10-CM requirement. The table below maps all M36 sibling codes so coders can confirm M36.8 is the appropriate selection before billing.
When the connective tissue disorder is linked to a neoplasm, a blood disorder, or a hypersensitivity reaction, the more specific M36.0-M36.4 codes take precedence over M36.8. Use M36.8 only when the underlying disease does not match any of those more specific subcategories. Practices using claims management software can flag these distinctions during pre-submission review.

ICD-10-CM coding guidelines for M36.8
Three guidelines from the ICD-10-CM Official Guidelines for Coding and Reporting apply directly to M36.8. These are published jointly by CMS and NCHS each fiscal year.
Etiology/manifestation convention
M36.8 is a manifestation code. Under the etiology/manifestation convention, manifestation codes cannot be reported as the principal diagnosis. The etiology (underlying disease) must always be sequenced first.
Signs and symptoms vs. definitive diagnosis
M36.8 requires a confirmed systemic connective tissue disorder as a manifestation of a coded underlying disease. Coders should not apply M36.8 based on signs or symptoms alone. The treating provider must document both the primary systemic disease and the connective tissue manifestation explicitly in the clinical notes.
HIPAA compliance for code submission
M36.8 is valid for HIPAA-covered transactions. All claims submitted with this code must use the current ICD-10-CM code set as required under HIPAA. Payers may request supporting documentation during audit. Practices can review HIPAA coding obligations through HIPAA compliance requirements for medical offices and the Pabau HIPAA compliance guidance.
Simplify diagnostic code documentation with Pabau
Pabau's claims management tools help rheumatology and internal medicine practices document etiology-manifestation code pairs, enforce sequencing rules, and submit HIPAA-compliant claims without post-encounter rework.
Clinical documentation requirements for M36.8
Incomplete documentation is the most frequently cited reason for M36.8 claim denials in rheumatology and internal medicine audits. The record needs to show a clear causal link between the underlying disease and the connective tissue manifestation, not just list the two diagnoses side by side.
To support a valid M36.8 code for a HIPAA-covered transaction, the clinical record must document all of the following:
- Named underlying disease: the primary systemic condition causing the connective tissue disorder must be explicitly documented (not inferred from test results alone)
- Systemic connective tissue involvement: the provider must document that connective tissue is affected as a direct manifestation of the primary disease, not as a coincidental finding
- Clinical assessment: the encounter note must reflect a clinical assessment linking the two conditions, typically in the assessment/plan section
- Causal relationship: the language in the record should establish that the connective tissue disorder is “due to,” “in,” or “associated with” the underlying disease; vague language like “history of” will not support the etiology/manifestation pair
Practices with integrated complex ICD-10 coding workflows often find that building documentation templates for high-frequency manifestation codes reduces query burden on providers.
A structured assessment section that prompts for both the primary diagnosis and secondary manifestations catches most sequencing errors at the time of documentation rather than during pre-bill review. Linking digital clinical forms to encounter types associated with systemic disease is one practical way to standardize this.

FY2026 code validity and recent history
ICD-10 Code M36.8 has been active without interruption since its effective date of October 1, 2015. It carries no deletion, revision, or transfer notice in the FY2026 ICD-10-CM tabular update files published by CMS and NCHS.
Coders should verify active status annually before the October 1 fiscal year start using the WHO ICD-10 browser for international context. For practices using ICD-10-CM codes across multiple specialties, HIPAA billing requirements apply to all code submissions regardless of the practice type.
Pro Tip
Set a calendar reminder for September each year to cross-check your high-frequency ICD-10-CM codes against the CMS annual tabular update files. CMS releases the FY update on October 1 each year. Catching deletions or revisions before payers update their systems prevents unexpected denials in Q1.
Conclusion
Manifestation codes like M36.8 create a specific audit risk that pure code lookups do not resolve: the etiology/manifestation sequencing requirement. Getting the code right is straightforward once the documentation reflects a clear causal relationship between the underlying disease and the connective tissue disorder.
Pabau’s claims management software helps practices build code-pairing workflows that enforce sequencing rules and flag missing documentation before submission, reducing the post-encounter rework that drives up coding costs. To see how Pabau handles diagnostic code documentation in practice, book a demo.
Continue your research
Coding another dual-sequenced manifestation code? M14.88 follows the same etiology-first sequencing logic for arthropathies in other diseases.
Need the code for a related connective tissue diagnosis? M35.1 covers other overlap syndromes in the same M30-M36 block.
Coding a related rheumatologic diagnosis? M06.1 covers Adult-onset Still’s disease.
Frequently asked questions
What is ICD-10 Code M36.8?
ICD-10 Code M36.8 is a billable ICD-10-CM diagnosis code for systemic disorders of connective tissue in other diseases classified elsewhere. It is a manifestation code, meaning it is used to capture connective tissue complications that arise as secondary findings from an underlying systemic disease coded elsewhere in ICD-10-CM.
Is M36.8 a billable ICD-10-CM code?
Yes, M36.8 is a billable, specific ICD-10-CM code valid for HIPAA-covered transactions. It has been billable since its effective date of October 1, 2015, and remains valid for FY2026 with no revisions or deletions in the current annual tabular.
What does ‘diseases classified elsewhere’ mean in ICD-10 coding?
“Diseases classified elsewhere” indicates a manifestation code: the condition described (here, systemic connective tissue disorder) is a secondary consequence of a primary disease that has its own code in a different part of ICD-10-CM. The underlying disease is always sequenced first per the etiology/manifestation convention.
When should I use M36.8 versus other M36 codes?
Use M36.8 only when the systemic connective tissue disorder does not fit a more specific M36 subcategory. If the underlying cause is a neoplasm, use M36.0 (dermato(poly)myositis) or M36.1 (arthropathy in neoplastic disease). If the cause is a blood disorder, use M36.2 or M36.3. M36.4 covers hypersensitivity reactions. M36.8 is the residual category for other underlying diseases not captured by M36.0 through M36.4.
What are the Excludes1 notes for M36.8?
M36.8 has no Excludes1 note in the ICD-10-CM tabular. There are no codes designated as mutually exclusive with M36.8, so no conditions are barred from being coded at the same encounter on Excludes1 grounds.
Is M36.8 valid for FY2026 billing?
Yes. M36.8 is confirmed valid for FY2026 HIPAA-covered transactions with no changes in the annual ICD-10-CM update files. Verify current status before each fiscal year using the CDC/NCHS ICD-10-CM tool.